Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics
- PMID: 22697261
- PMCID: PMC3441352
- DOI: 10.1186/2045-7022-2-10
Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics
Abstract
Background: In the general population, reports on suspected ß-lactam hypersensitivity are common. After a drug allergy work-up at best 20% of the selected patients are positive. However, these considerations have not been explored in cystic fibrosis patients for whom antibiotics are even more crucial.
Methods: The study, part of the Drug Allergy and Hypersensitivity (DAHD) cohort, was performed in the regional cystic fibrosis center of Montpellier, France. After identifying patients with a clinical history suggestive of drug allergy to ß-lactams, a complete drug allergy work-up, was carried out according to the EAACI recommendations.
Results: Among the 171 patients involved, 23 reported clinical manifestations potentially compatible with a drug allergy to ß-lactams. After performing the complete drug-allergy work-up, 7 were considered as drug hypersensitive (3 had positive skin tests, 1 a positive provocation test, 3 declined the tests). Excluding the latter 3 patients with incomplete drug allergy work-up, the rate of proven drug allergy was 2.3%.
Conclusions: Drug allergy to ß-lactams in cystic fibrosis patients is of importance. A full drug allergy work-up is mandatory in case of suspicion, because ß-lactam responsibility is often ruled out.
Figures
Similar articles
-
Allergy to beta-lactam antibiotics in children.Pediatrics. 1999 Oct;104(4):e45. doi: 10.1542/peds.104.4.e45. Pediatrics. 1999. PMID: 10506270
-
Beta-lactam hypersensitivity in children with cystic fibrosis: a study in a specialized pediatric center for cystic fibrosis and drug allergy.Pediatr Allergy Immunol. 2014 Feb;25(1):88-93. doi: 10.1111/pai.12154. Epub 2013 Nov 18. Pediatr Allergy Immunol. 2014. PMID: 24237053
-
Designing Predictive Models for Beta-Lactam Allergy Using the Drug Allergy and Hypersensitivity Database.J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):139-148.e2. doi: 10.1016/j.jaip.2017.04.045. Epub 2017 Jul 21. J Allergy Clin Immunol Pract. 2018. PMID: 28739365
-
Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing.J Allergy Clin Immunol Pract. 2019 Jan;7(1):40-45. doi: 10.1016/j.jaip.2018.07.051. Epub 2018 Sep 20. J Allergy Clin Immunol Pract. 2019. PMID: 30245291 Review.
-
Allergy to antibiotics in children: an overestimated problem.Int J Antimicrob Agents. 2016 Oct;48(4):361-6. doi: 10.1016/j.ijantimicag.2016.08.001. Epub 2016 Aug 12. Int J Antimicrob Agents. 2016. PMID: 27554439 Review.
Cited by
-
Antibiotic Allergy in Pediatrics.Pediatrics. 2018 May;141(5):e20172497. doi: 10.1542/peds.2017-2497. Pediatrics. 2018. PMID: 29700201 Free PMC article. Review.
-
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk.Mol Diagn Ther. 2023 May;27(3):395-403. doi: 10.1007/s40291-023-00644-3. Epub 2023 Mar 20. Mol Diagn Ther. 2023. PMID: 36939981
-
Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.J Allergy Clin Immunol. 2015 Aug;136(2):262-71.e2. doi: 10.1016/j.jaci.2015.05.027. J Allergy Clin Immunol. 2015. PMID: 26254053 Free PMC article.
-
The challenge of de-labeling penicillin allergy.Allergy. 2020 Feb;75(2):273-288. doi: 10.1111/all.13848. Epub 2019 May 26. Allergy. 2020. PMID: 31049971 Free PMC article. Review.
-
Risk factors for drug hypersensitivity reactions in children.Ital J Pediatr. 2024 Jul 15;50(1):127. doi: 10.1186/s13052-024-01694-x. Ital J Pediatr. 2024. PMID: 39010141 Free PMC article. Review.
References
-
- Ballmanna M, Smythb A, Gellerc DE. Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics. Respir Med. 2011;105(Suppl2):2–8. - PubMed
-
- Fernandes B, Plummer A, Wildman M. Duration of intravenous antibiotic therapy in people with cystic fibrosis. Cochrane Database Syst Rev. 2008;2:CD006682. - PubMed
-
- Sermet-Gaudelus I, Ferroni A, Gaillard JL, Silly C, Chretiennot C, Lenoir G, Berche P. Antibiotic therapy in cystic fibrosis. II Antibiotic strategy. Arch Pediatr. 2000;7:645–656. - PubMed
LinkOut - more resources
Full Text Sources